Skip to content

A Study of Yoga for Treating Geriatric Insomnia

A Mixed Design, With Wait List Control Crossover to Intervention, Clinical Trial of Integrated Yoga Style Practice Intervention for Improving Sleep and Quality of Life in the Elderly Population

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00661843
Enrollment
74
Registered
2008-04-18
Start date
2008-05-31
Completion date
2009-02-28
Last updated
2010-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Geriatric Insomnia, Sleep Initiation and Maintenance Disorders

Keywords

insomnia, geriatric, yoga, sleep, electrocardiogram

Brief summary

Insomnia is common in the elderly population and is associated with increased health problems, reduced quality of life and greater use of sleep inducing drugs. This research aims to examine the effectiveness of Yoga practice to treat insomnia in elderly people, determine the ability to enhance their quality of life and determine if it is suitable to western culture and conditions.

Detailed description

Introduction: Geriatric insomnia is prevalent, reducing life quality, diminishing cognition and increasing risk of accidents and mortality. Treatment with sedative-hypnotic drugs has limited effectiveness and further increases the risk of accidents and falls. Yoga has been shown to increase well-being in the elderly. Hypotheses 1. Integrated yoga style practice can improve sleep quality/quantity 2. Integrated yoga style practice can improve quality of life. Objectives: 1. Examine effectiveness of yoga for insomnia and reduction in use of hypnotics/relaxants in the elderly; 2. Determine whether yoga enhances quality of life in the elderly; and 3. Determine whether yoga is suitable for elderly in western culture(s). Methods: A mixed design crossover controlled trial (n =74, age range 60-87, M = 74.4, SD = 7.1) with 2 weekly classes incorporating physical and meditative yoga, and daily home practice of meditative yoga for 12 weeks. Measures included self-reported assessment of sleep quality (Sleep Logs, KSS, ESS, PSQI, MAPS), mood states (DASS, POMS), general health (SF-36) and mobile objective home sleep studies.

Interventions

OTHERIntegrated Yoga style practice

Intervention constitutes of 2 supervised yoga style classes per week incorporating gentle postures,relaxation and meditation sequences. In addition daily home based sessions of yogic relaxation, and meditation a an audio CD

Sponsors

KTH Royal Institute of Technology
CollaboratorOTHER
The Australia-Israel Scientific Exchange Foundation (AISEF)
CollaboratorOTHER
Israel Yoga Teachers Association
CollaboratorUNKNOWN
Shaare Zedek Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 60 years or older * Independent, self mobile * Suffering from light to severe primary insomnia

Exclusion criteria

* Age less than 60 years * Currently or in the past engaged in regular yoga practice * Suffering from any physical or mental health condition or disability which may affect sleep, or for which Yoga practice is counter indicated or may lead to health risks or complications. * Suffering from co-morbid insomnia in conjunction with another condition clearly salient to sleep disturbance.

Design outcomes

Primary

MeasureTime frameDescription
Subjective sleep and life quality assessment using standard questionnaires and sleep logs24 weeksall measures taken at baseline and post intervention for all participants participant who crossed over measured pre and post control phase and post intervention phase
Objective home based sleep studies using24 weeksobjective sleep studies using embletta mobile sleep recording system in conjunction with the HPC1000 sleep analysis system. all measures taken pre and post intervention. Participants who crossed over measured pre control, post control and post intervention phases

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026